Columbus Circle Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-575,542
Closed -$82.3M 315
2017
Q3
$82.3M Sell
575,542
-183,235
-24% -$25M 1.4% 17
2017
Q2
$98.5M Sell
758,777
-93,999
-11% -$11.5M 1.63% 11
2017
Q1
$106M Sell
852,776
-194,522
-19% -$23.3M 1.49% 12
2016
Q4
$121M Buy
1,047,298
+446,882
+74% +$49.8M 1.58% 12
2016
Q3
$62.8M Buy
600,416
+570,345
+1,897% +$61.7M 0.68% 49
2016
Q2
$2.97M Sell
30,071
-51,135
-63% -$5.29M 0.03% 205
2016
Q1
$8.13M Sell
81,206
-76,817
-49% -$7.91M 0.07% 195
2015
Q4
$18.9M Buy
158,023
+51,189
+48% +$5.92M 0.15% 143
2015
Q3
$11.6M Buy
+106,834
New +$13.3M 0.09% 179
2015
Q2
Sell
-849,527
Closed -$97.9M 338
2015
Q1
$97.9M Buy
849,527
+103,830
+14% +$12.4M 0.67% 44
2014
Q4
$83.4M Buy
745,697
+711,558
+2,084% +$75M 0.59% 50
2014
Q3
$3.24M Sell
34,139
-182,115
-84% -$16.4M 0.02% 217
2014
Q2
$18.6M Buy
+216,254
New +$16.4M 0.13% 153
2014
Q1
Sell
-355,956
Closed -$30.1M 371
2013
Q4
$30.1M Buy
355,956
+4,320
+1% +$342K 0.21% 128
2013
Q3
$27.1M Buy
351,636
+32,096
+10% +$2.25M 0.19% 136
2013
Q2
$18.7M Buy
+319,540
New +$19.2M 0.15% 159

Other funds holding CELG

Columbus Circle Investors's CELG Position: Q4 2017 in Review

Columbus Circle Investors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 575,542 shares — an estimated $82.3M sold.

Columbus Circle Investors first reported a position in CELG in Q2 2013 and held it in 16 quarters. The position peaked at $121M in Q4 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Columbus Circle Investors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 575,542 Celgene Corp shares in Q4 2017, an estimated $82.3M.
  • Columbus Circle Investors first reported a position in Celgene Corp in Q2 2013 and held it in 16 quarters.
  • Columbus Circle Investors's Celgene Corp position peaked at $121M in Q4 2016.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.